Senseonics Receives MRI Approval for Eversense Implantable CGM
Senseonics announced that its Eversense implantable CGM has been approved for MRI-compatibility (i.e. patients can receive an MRI without the sensor having to be extracted). Of note, patients must still remove the external transmitter prior to the MRI procedure. Below, FENIX provides thoughts on how this label update could impact Eversense uptake.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.